AMPH — Amphastar Pharmaceuticals, Share News
0.000.00%
Last trade - 00:00- $885.83m
- $1.21bn
- $719.89m
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing
U.S. RESEARCH ROUNDUP-Cars.Com, Dell, Zscaler
Amphastar Q4 revenue misses estimates
Brief: Amphastar Pharmaceuticals Q4 EPS USD 0.51
Brief: Amphastar Announces FDA Approval for Teriparatide Injection
Amphastar Pharmaceuticals Q3 revenue beats estimates
Brief: Amphastar Pharmaceuticals Q3 EPS USD 0.37
Brief: Amphastar Pharmaceuticals Enters Contract Research Agreement With Hanxin -SEC Filing
Brief: Amphastar Pharmaceuticals Enteres License Agreement With Nanjing Anji Biotechnology
Amphastar Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.64
U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, Comstock, Range Resources
Amphastar Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Amphastar Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary
U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, Guardant Health, Upwork
Amphastar Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary